Our in vitro results advise that EAM-2201 ought to be examined when it comes to possible in vivo pharmacokinetic drug–drug interactions a result of time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 routines and competitive inhibition of UGT1A3 activity. The website is secure. The https:// ensures that you are connecting https://charlieg050ods3.life-wiki.com/user